Article

Prognostic and Therapeutic Relevance of BRCA1/2 Zygosity in Prostate Cancer: A Multicohort Desk-Based Analysis

2026-02-16

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> BRCA1/2 alterations are increasingly recognized as biologically and clinically relevant features in prostate cancer, yet the prognostic and therapeutic significance of zygosity status remains uncertain. Understanding differences between monoallelic and biallelic inactivation may refine risk stratification and guide therapeutic decision-making. <h4>Materials and Methods</h4...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0d86c82c-a799-50c2-a598-96a43967b48a
DOI: 10.64898/2026.02.13.26346266

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prognostic and Therapeutic Relevance of BRCA1/2 Zygosity in Prostate Cancer: A Multicohort Desk-Based AnalysisDOI 10.64898/2026.02.13.26346266Read

Prostate cancer genotyping for risk stratification and precision treatmentSemantic proximity Read

Homologous recombination deficiency and genomic alterations in advanced prostate cancer: insights for precision therapy.Semantic proximity Read

BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.Semantic proximity Read

BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.Semantic proximity Read

Predisposition to prostate cancer and clinical implications in a real-life cohort.Semantic proximity Read

BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype.Semantic proximity Read

Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival.Semantic proximity Read

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.Semantic proximity Read

BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis.Semantic proximity Read

Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesSemantic proximity Read

Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer.Semantic proximity Read

Biallelic BRCA2 Mutations Shape the Somatic Mutational Landscape of Aggressive Prostate Tumors.Semantic proximity Read